Triple

T1143273
Position Surface form Disambiguated ID Type / Status
Subject Regulation (EC) No 726/2004 E23503 entity
Predicate establishes P986 FINISHED
Object Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
E130559 NE FINISHED

How this triple was built (4 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Pharmacovigilance Risk Assessment Committee within the European Medicines Agency | Statement: [Regulation (EC) No 726/2004, establishes, Pharmacovigilance Risk Assessment Committee within the European Medicines Agency]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
Context triple: [Regulation (EC) No 726/2004, establishes, Pharmacovigilance Risk Assessment Committee within the European Medicines Agency]
  • A. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • B. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • C. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • D. Committee for Medicinal Products for Veterinary Use
    The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
  • E. UK Medicines and Healthcare products Regulatory Agency
    The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
  • F. None of above. chosen
  • G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg Description generation gpt-5.1
Instruction
Generate a one-sentence description of the target entity. 
You are given a context triple in the form (subject, predicate, object), where the object is the target entity. 
# Instructions
Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. 
Avoid repeating the information from the triple, unless really essential.
# Response Format
Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
Triple: [Regulation (EC) No 726/2004, establishes, Pharmacovigilance Risk Assessment Committee within the European Medicines Agency]
Generated description
The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
NED2 Entity disambiguation (via description) gpt-5-mini-2025-08-07
Target entity: Pharmacovigilance Risk Assessment Committee within the European Medicines Agency
Target entity description: The Pharmacovigilance Risk Assessment Committee within the European Medicines Agency is an expert body responsible for evaluating and monitoring the safety of medicines across the European Union and providing recommendations on managing and communicating medicine-related risks.
  • A. European Medicines Agency
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • B. Committee for Proprietary Medicinal Products
    The Committee for Proprietary Medicinal Products was a former scientific committee of the European Union responsible for evaluating and issuing opinions on the quality, safety, and efficacy of human medicinal products before it was replaced by the European Medicines Agency’s current committee structure.
  • C. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • D. Committee for Medicinal Products for Veterinary Use
    The Committee for Medicinal Products for Veterinary Use is the European Medicines Agency’s scientific committee responsible for evaluating and providing opinions on veterinary medicines in the European Union.
  • E. UK Medicines and Healthcare products Regulatory Agency
    The UK Medicines and Healthcare products Regulatory Agency is the United Kingdom’s national authority responsible for regulating medicines, medical devices, and healthcare products to ensure their safety, quality, and effectiveness.
  • F. None of above. chosen

Provenance (5 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69a493ef399c8190b04b9146d2314f59 completed March 1, 2026, 7:30 p.m.
NER Named-entity recognition batch_69a4bc4e93d48190b9fea886bf61aad7 completed March 1, 2026, 10:23 p.m.
NED1 Entity disambiguation (via context triple) batch_69ac59b2395c81909d4608bdaf1d57e8 completed March 7, 2026, 5 p.m.
NEDg Description generation batch_69ac5b52c43c8190b8972826a9a1ea5f completed March 7, 2026, 5:07 p.m.
NED2 Entity disambiguation (via description) batch_69ac5be4d9548190a0f1d57538f688c1 completed March 7, 2026, 5:09 p.m.
Created at: March 1, 2026, 7:44 p.m.